Burning Rock Biotech Ltd
company in Beijing, China
BNR Nasdaq
SEC CIK 1792267
Follow Burning Rock Biotech
Weekly email: filings, results, news
EPS, diluted
-
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | CNY 539.6M | −CNY 55.3M |
| FY24 | CNY 515.8M | −CNY 346.6M |
| FY23 | CNY 537.4M | −CNY 653.7M |
| FY22 | CNY 563.2M | −CNY 971.2M |
| FY21 | CNY 507.9M | −CNY 796.7M |
| FY20 | CNY 429.9M | −CNY 407.2M |
| FY19 | CNY 381.7M | −CNY 169.2M |
| FY18 | CNY 208.9M | −CNY 177.5M |
| FY17 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 74.7% | −10.2% | −10.3% |
| FY24 | 70.3% | −69.3% | −67.2% |
| FY23 | 67.6% | −124.5% | −121.6% |
| FY22 | 67.5% | −174.1% | −172.4% |
| FY21 | 71.7% | −156.9% | −156.9% |
| FY20 | 73% | −95.9% | −94.7% |
| FY19 | 71.6% | −44.3% | −44.3% |
| FY18 | 64.7% | −77.3% | −85% |
| FY17 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −CNY 33.7M |
| FY24 | −CNY 97.7M |
| FY23 | −CNY 263.9M |
| FY22 | −CNY 518.8M |
| FY21 | −CNY 682.2M |
| FY20 | −CNY 133.8M |
| FY19 | −CNY 271M |
| FY18 | −CNY 172M |
| FY17 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | - |
| FY22 | - |
| FY21 | CNY 0 |
| FY20 | CNY 0 |
| FY19 | CNY 3.6M |
| FY18 | CNY 0 |
| FY17 | - |
- Burning Rock Biotech
- Healthcare median
Show the numbers
| Year | Burning Rock Biotech | Healthcare median |
|---|---|---|
| FY25 | −10.3% | −66.4% |
| FY24 | −67.2% | −87% |
| FY23 | −121.6% | −128.5% |
| FY22 | −172.4% | −143.6% |
| FY21 | −156.9% | −137.7% |
| FY20 | −94.7% | −134.3% |
| FY19 | −44.3% | −125.9% |
| FY18 | −85% | −172.7% |
| FY17 | - | −166.7% |
News
No stories filed under Burning Rock Biotech yet - coverage appears here as the news feed clusters it.